Bladder cancer originates from the cells lining the bladder and is one of the cancers commonly encountered in urology. The disease's stage, the tumor's invasion of the bladder wall, and the patient's general health are the key factors determining the treatment method to be used.
In suitable patients, robotic surgery is considered a modern, minimally invasive option for the surgical treatment of bladder cancer. This approach offers more controlled and safe surgical intervention, especially in delicate anatomical areas.
Diagnosing bladder cancer involves endoscopic examination, imaging and pathological assessment together. The tumor's depth within the bladder wall, its relationship to surrounding tissue and its possible extent are assessed in detail to determine the disease's stage.
This evaluation guides the suitability of robotic surgery and the scope of the surgical plan.
Robotic surgery for bladder cancer allows precise, controlled intervention thanks to high-resolution 3D visualization and enhanced surgical dexterity. Depending on the disease's stage, removal of part or all of the bladder can be planned.
The robotic approach can provide advantages such as preserving surrounding tissue, less bleeding, a shorter hospital stay and a faster recovery. With proper patient selection, safe and effective surgical results are the aim.
After surgery, patients are placed on a regular follow-up program. Oncologic surveillance, general health and quality of life are assessed at check-ups. Additional treatment or supportive approaches may be planned if needed.
The main goal of the treatment process is to control the disease, reduce the risk of recurrence and preserve the patient's quality of life.
